Literature DB >> 7203562

Effect of gene dosage on cell-surface expression of Thy-1 antigen in somatic cell hybrids between Thy-1- Abelson-leukemia-virus induced lymphomas and Thy-1+ mouse lymphomas.

R Hyman, K Cunningham, V Stallings.   

Abstract

Hybrids between pseudodiploid Thy-1.1+ lymphomas and Thy 1.2- pseudodiploid Abelson-leukemia-virus-induced-(ALV-induced) lymphomas express Thy-1 glycoprotein on their cell surface. These Thy-1+ hybrids invariably express the Thy 1.1 allelic form of the glycoprotein and may be either Thy 1.2+ or Thy 1.2-. Sublines expressing both Thy 1.1 and Thy 1.2 can be isolated from Thy 1.1+, Thy 1.2- hybrids by cell sorting. In contrast to hybrids with pseudodiploid ALV-induced lymphomas, hybrids between Thy 1.1+ lymphomas and pseudotetraploid Thy 1.2- Abelson-leukemia-virus-induced lymphomas do not express Thy-1 glycoprotein on their cell surface and Thy-1 glycoprotein cannot be detected in detergent extracts of these cells. Thy-1+ revertants were isolated from one of the Thy-1- hybrids by cell sorting. - These results demonstrate a gene dosage effect for the expression of the Thy-1 glycoprotein in somatic cell hybrids. They are consistent with the idea that diffusable gene products regulate Thy-1-glycoprotein expression in these hybrids. They also suggest that there may be additional, apparently cis-active, regulatory mechanisms which determine the ability of the Thy-1 structural genes of the Abelson-leukemia-virus-induced lymphoma parent to be expressed in somatic cell hybrids.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7203562     DOI: 10.1007/bf01561678

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  22 in total

1.  Expression of Thy 1.2 antigen on hybrids of B cells and a T lymphoma.

Authors:  G M Iverson; R A Goldsby; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

Review 2.  Gene expression in somatic cell hybrids.

Authors:  R L Davidson
Journal:  Annu Rev Genet       Date:  1974       Impact factor: 16.830

3.  Studies on surface antigen variants. Isolation of two complementary variants for Thy 1.2.

Authors:  R Hyman
Journal:  J Natl Cancer Inst       Date:  1973-02       Impact factor: 13.506

4.  Fusion of T and B cells.

Authors:  G Köhler; T Pearson; C Milstein
Journal:  Somatic Cell Genet       Date:  1977-05

5.  Chromatin repeat length correlates with phenotypic expression in hepatoma cells, their dedifferentiated variants, and somatic hybrids.

Authors:  L Sperling; M C Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

6.  Chromosome stability in CHO cells.

Authors:  R G Worton; C C Ho; C Duff
Journal:  Somatic Cell Genet       Date:  1977-01

7.  Cell-free synthesis and membrane insertion of mouse H-2Dd histocompatibility antigen and beta 2-microglobulin.

Authors:  B Dobberstein; H Garoff; G Warren; P J Robinson
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

8.  Immunoglobulin synthesis by lymphoid cells transformed in vitro by Abelson murine leukemia virus.

Authors:  E J Siden; D Baltimore; D Clark; N E Rosenberg
Journal:  Cell       Date:  1979-02       Impact factor: 41.582

9.  The synthesis and properties of T25 blycoprotein in Thy-1-negative mutant lymphoma cells.

Authors:  I S Trowbridge; R Hyman; C Mazauskas
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

10.  Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus.

Authors:  A Marshak-Rothstein; P Fink; T Gridley; D H Raulet; M J Bevan; M L Gefter
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

View more
  12 in total

1.  Rearrangement of T-cell receptor beta-chain genes during T-cell development.

Authors:  W Born; J Yagüe; E Palmer; J Kappler; P Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

2.  Regulation of Thy-1 and Pgp-1 glycoproteins in hybrids between T-cell lymphomas and Abelson-leukemia-virus-induced lymphomas.

Authors:  R Hyman; K Cunningham
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

3.  Sequential activation and loss of the pre-B cell Thy-1 gene in T-cell X pre-B cell somatic hybrids.

Authors:  R Hyman; K Clarkin
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

Review 4.  Cell-surface-antigen mutants of haematopoietic cells. Tools to study differentiation, biosynthesis and function.

Authors:  R Hyman
Journal:  Biochem J       Date:  1985-01-01       Impact factor: 3.857

5.  Elf-1 binds to a critical element in a second CD4 enhancer.

Authors:  A L Wurster; G Siu; J M Leiden; S M Hedrick
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

6.  Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues.

Authors:  I S Trowbridge; J Lesley; R Schulte; R Hyman; J Trotter
Journal:  Immunogenetics       Date:  1982-03       Impact factor: 2.846

7.  Expression of the Thy-1 glycoprotein gene by DNA-mediated gene transfer.

Authors:  G A Evans; H A Ingraham; K Lewis; K Cunningham; T Seki; T Moriuchi; H C Chang; J Silver; R Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

8.  Genetic basis for Ly-6- defect: complementation between Ly-6- and Thy-1- mutant cell lines.

Authors:  M A Horton; R Hyman
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

9.  Molecular characterization of the murine cytotoxic T-cell membrane glycoprotein Ly-3 (CD8).

Authors:  M Panaccio; M T Gillespie; I D Walker; L Kirszbaum; J A Sharpe; G H Tobias; I F McKenzie; N J Deacon
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

10.  A Thy-1- mutant defining a gene acting in trans position to regulate cell-surface Thy-1 glycoprotein expression and Thy-1 messenger RNA content.

Authors:  R Hyman; K Cunningham
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.